(NASDAQ: ASRT) Assertio Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 14.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.37%.
Assertio Holdings's earnings in 2026 is -$30,375,000.On average, 6 Wall Street analysts forecast ASRT's earnings for 2026 to be -$1,134,348, with the lowest ASRT earnings forecast at -$5,242,494, and the highest ASRT earnings forecast at $4,195,800. On average, 5 Wall Street analysts forecast ASRT's earnings for 2027 to be $12,972,820, with the lowest ASRT earnings forecast at $1,515,902, and the highest ASRT earnings forecast at $30,927,105.
In 2028, ASRT is forecast to generate $41,548,086 in earnings, with the lowest earnings forecast at $39,918,749 and the highest earnings forecast at $42,770,088.